Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

CONVENIENTMD LLC

NPI: 1467048348 · SALEM, NH 03079 · Clinical Medical Laboratory · NPI assigned 12/15/2020

Billing Flags · Automated signals — not evidence of fraud
Entity Proliferation

Authorized official BOISSONNEAULT, JAROD controls 20+ related entities in our dataset. Read more

$876K
Total Medicaid Paid
22,974
Total Claims
21,156
Beneficiaries
2
Codes Billed
2021-02
First Month
2023-04
Last Month

Provider Details

Authorized OfficialBOISSONNEAULT, JAROD (DIRECTOR OF REVENUE CYCLE MGT)
NPI Enumeration Date12/15/2020

Related Entities

Other providers sharing the same authorized official: BOISSONNEAULT, JAROD

ProviderCityStateTotal Paid
CONVENIENTMD - FFS UC LLC AUGUSTA ME $517K
CONVENIENTMD - FFS UC LLC BANGOR ME $509K
CONVENIENTMD LLC NORTH ANDOVER MA $401K
CONVENIENTMD - FFS UC LLC AUBURN ME $392K
CONVENIENTMD - FFS UC LLC BELLINGHAM MA $388K
CONVENIENTMD LLC AUGUSTA ME $360K
CONVENIENTMD - FFS UC LLC PLYMOUTH MA $352K
CONVENIENTMD - FFS UC LLC ELLSWORTH ME $328K
CONVENIENTMD LLC DEDHAM MA $323K
CONVENIENTMD - FFS UC LLC BRUNSWICK ME $297K
CONVENIENTMD - FFS UC LLC PITTSFIELD MA $266K
CONVENIENTMD LLC LONDONDERRY NH $261K
CONVENIENTMD - FFS UC LLC NORTH ANDOVER MA $258K
CONVENIENTMD - FFS UC LLC WESTBROOK ME $255K
CONVENIENTMD LLC ELLSWORTH ME $253K
CONVENIENTMD LLC PEABODY MA $248K
CONVENIENTMD - FFS UC LLC PLAINVILLE MA $242K
CONVENIENTMD - FFS UC LLC FRAMINGHAM MA $215K
CONVENIENTMD - FFS UC LLC SACO ME $201K
CONVENIENTMD LLC LEOMINSTER MA $199K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2021 7,564 $243K
2022 14,234 $583K
2023 1,176 $50K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 11,575 10,593 $675K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 11,399 10,563 $200K